Member of Lyonbiopole
AIS Biotech (with AIS for Anti Infective Sugar) is a French Biotech company based in the Alps incorporated in March 2023 with the objective of developing a new class of anti-infective biotherapeutics.
AIS Biotech is dedicated to the development of Innovative sugar-based biotherapeutics to fight against (re)emerging infectious diseases.
Thanks to a sustainable Bioengineering plateform based on the expertise of a leading edge academic laboratory (CERMAV, CNRS, Grenoble FRANCE), AIS Biotech aims to develop a pipeline of innovative sugar-based anti-infective biopharmaceuticals.
By mimicking the natural host surface oligosaccharide binding-sites of pathogens, our compounds act as decoy receptors to prevent or treat the infection.
GlycoFlu, our first drug-candidate is developed to treat infection by human Influenza viruses, a global public health concern with a large socio-economic impact.
Application market: Infectious Diseases
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Biomaterials, Others
Created on march 27th, 2023 - 4 employees
Address
22 rue Saint Fergus 38000 Grenoble
You must be logged in and a member of Lyonbiopôle to see the contacts.
